Wezlana

List of products in the National Drug Code with proprietary name wezlana. Ustekinumab is used to treat plaque psoriasis, a certain type of arthritis (psoriatic arthritis), or certain bowel conditions (Crohn's disease, ulcerative colitis). It works by blocking certain natural proteins in your body (interleukin-12 and interleukin-23) that cause inflammation (swelling) in these conditions. Ustekinumab does not cure these diseases, but helps to lessen symptoms of the disease. It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
84612-055Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedHuman Prescription Drug
84612-066Wezlana Ustekinumab-auubInjection, SolutionIntravenousNuvaila LimitedHuman Prescription Drug
84612-076Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedHuman Prescription Drug
84612-089Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedHuman Prescription Drug
84612-855Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedHuman Prescription Drug
84612-876Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedHuman Prescription Drug
84612-889Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedHuman Prescription Drug